hsa-miR-761

ncRNA information

ncRNA name

hsa-miR-761

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Synovial Sarcoma

Cancer site

None

Treatment information

Treatment type

Chemotherapy

Drug

Pazopanib

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Extracellular vesicle-encapsulated microRNA-761 enhances pazopanib resistance in synovial sarcoma.

Tissue resource

synovial sarcoma cell lines SYO-1

synovial sarcoma cell lines HS-SYII

synovial sarcoma cell lines 1273/99

synovial sarcoma cell lines YaFuSS

Experiment

qRT-PCR


Institute

National Cancer Center Hospital

Kochi Medical School

Karolinska Institute

University of Tokyo

Country

Japan

Sweden

China

Continent

Asia